Literature DB >> 8545771

Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients.

A Nicolato1, M A Gerosa, P Fina, P Iuzzolino, F Giorgiutti, A Bricolo.   

Abstract

A retrospective uni-multivariate statistical analysis was performed on 32 prognostic factors to investigate their importance in predicting survival in a series of 76 adult patients with low-grade supratentorial astrocytomas treated over a 13-year period. The end point used for this study was the length of survival. The median survival time was 40 months. Overall actuarial survival at 2, 5, and 10 years was 69%, 38%, and 22%, respectively. Radical resection of the neoformation, a higher preoperative Karnofsky performance status (KPS) score, and an age younger than 50 years are strongly correlated with survival; postoperative radiotherapy appears to be associated with increased survival only in patients under 50 years of age.

Entities:  

Mesh:

Year:  1995        PMID: 8545771     DOI: 10.1016/0090-3019(95)00184-0

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  22 in total

Review 1.  Operative techniques for gliomas and the value of extent of resection.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 2.  Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome.

Authors:  M S Berger; R C Rostomily
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

3.  Gross-total surgery of supratentorial low-grade gliomas under intraoperative MR guidance.

Authors:  J P Schneider; T Schulz; F Schmidt; J Dietrich; S Lieberenz; C Trantakis; V Seifert; S Kellermann; R Schober; L Schaffranietz; M Laufer; T Kahn
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

4.  Response to postoperative radiotherapy as a prognostic factor for patients with low-grade gliomas.

Authors:  Michal Spych; Leszek Gottwald; Emilia Jesień-Lewandowicz; Sławomir Sztajer; Jacek Fijuth
Journal:  Oncol Lett       Date:  2012-06-14       Impact factor: 2.967

5.  Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics.

Authors:  Ion-Florin Talos; Kelly H Zou; Lucila Ohno-Machado; Jui G Bhagwat; Ron Kikinis; Peter M Black; Ferenc A Jolesz
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

6.  Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.

Authors:  Barbara J Fisher; Chen Hu; David R Macdonald; Glenn J Lesser; Stephen W Coons; David G Brachman; Samuel Ryu; Maria Werner-Wasik; Jean-Paul Bahary; Junfeng Liu; Arnab Chakravarti; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-01-30       Impact factor: 7.038

7.  CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients.

Authors:  A Salmaggi; M Gelati; B Pollo; C Marras; A Silvani; M R Balestrini; M Eoli; L Fariselli; G Broggi; A Boiardi
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

8.  Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival.

Authors:  Chikezie I Eseonu; Francisco Eguia; Karim ReFaey; Oscar Garcia; Fausto J Rodriguez; Kaisorn Chaichana; Alfredo Quinones-Hinojosa
Journal:  J Neurooncol       Date:  2017-05-19       Impact factor: 4.130

9.  Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.

Authors:  Johan Pallud; Laurent Capelle; Luc Taillandier; Denys Fontaine; Emmanuel Mandonnet; Rémy Guillevin; Luc Bauchet; Philippe Peruzzi; Florence Laigle-Donadey; Michèle Kujas; Jacques Guyotat; Marie-Hélène Baron; Karima Mokhtari; Hugues Duffau
Journal:  Neuro Oncol       Date:  2008-08-12       Impact factor: 12.300

10.  Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.

Authors:  David A Schomas; Nadia N Laack; Paul D Brown
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.